Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant genes » significant gender (Expand Search), significant benefits (Expand Search), significant changes (Expand Search)
significant cause » significant change (Expand Search), significant changes (Expand Search), significant gap (Expand Search)
Showing 2,141 - 2,160 results of 21,342 for search '(( significant decrease decrease ) OR ( ((significant genes) OR (significant cause)) decrease ))', query time: 0.58s Refine Results
  1. 2141
    Cis-acting elements in the promoter of PtWRKYs.

    Cis-acting elements in the promoter of PtWRKYs. by Yuzhao Ma (12840632)

    Published 2025
    “…Based on RNA-Seq, we identified 83 <i>WRKYs</i> significantly respond to cadmium (Cd) stress. Subsequently, we conducted a study on <i>WRKY95</i>, which was significantly up-regulated in the roots, stems, and leaves under Cd stress. …”
    Save to List
    Saved in:
  2. 2142
    The primer sequences for RT-qPCR.

    The primer sequences for RT-qPCR. by Yuzhao Ma (12840632)

    Published 2025
    “…Based on RNA-Seq, we identified 83 <i>WRKYs</i> significantly respond to cadmium (Cd) stress. Subsequently, we conducted a study on <i>WRKY95</i>, which was significantly up-regulated in the roots, stems, and leaves under Cd stress. …”
    Save to List
    Saved in:
  3. 2143
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 2144
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 2145
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 2146
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 2147
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 2148
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 2149
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 2150
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 2151
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 2152
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 2153
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 2154
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 2155
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 2156
    Test soil parameters.

    Test soil parameters. by Yonggang Huang (223155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 2157
    Differences in immune infiltration between NAFLD and control groups.

    Differences in immune infiltration between NAFLD and control groups. by Jiyong Zhang (2498740)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 2158
    Swelling pressure versus free swelling ratio curve.

    Swelling pressure versus free swelling ratio curve. by Yonggang Huang (223155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 2159
    Shematic representation for the mechanism of the swelling pressure: (a)soil without added fiber; (b)soil with added fiber.

    Shematic representation for the mechanism of the swelling pressure: (a)soil without added fiber; (b)soil with added fiber. by Yonggang Huang (223155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 2160
    Influence of UHMWPE length on swelling pressure.

    Influence of UHMWPE length on swelling pressure. by Yonggang Huang (223155)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: